Buy stocks
Invest and track all your stocks in one place.
Jubilant Life Sciences LtdNSE: JUBLPHARMA
NSE: JUBLPHARMA
₹688.50
+12.45
(3 May)
+1.8%
Loading chart
1D
1W
3M
1Y
5Y
Price
₹688.50
Today’s high
₹688.50
Today’s low
₹668.10
52W high
₹724.00
52W low
₹306.00
1Y
120.5%
PE
288.08
PB
2.02
EPS (TTM)
-3.83
Dividend yield
0.7%
5Y
4.9%
Market cap
₹10,902.4 Cr
Volume
7,359
Average volume
29,691
Insights
JUBLPHARMA has made a new 52 Wk high. 52 Wk high stocks tend to outperform in the near term.
JUBLPHARMA price is above its 200 day moving average
JUBLPHARMA PE is in the top end of its range over the past 2 years
JUBLPHARMA PE is in the highest 10% across all stocks. The market is valuing it as a growth stock on an earnings basis.
In beta. Send feedback here.
Compare with other stock
Price
₹1,663.00
₹688.50
₹1,152.50
₹1,508.40
₹6,332.85
₹3,937.05
1D
+0.9%
+1.8%
-0.1%
-0.7%
+0.7%
-0.7%
1Y
+134.7%
+120.5%
+86.4%
+55.1%
+27.8%
+21.0%
PE
42.45
288.08
24.40
40.66
20.21
75.55
PB
5.72
2.02
2.40
6.05
3.94
8.24
EPS
39.18
2.39
47.24
37.10
313.29
52.11
Market cap
Large
Large
Large
Large
Large
Large
Financials
Income statement
Balance sheet
Cash flow
Quarterly
Annual
As of 2022
Revenue
₹6,219.3 Cr
Net income
- ₹61.0 Cr
See stock holdings
Top institutional holders
Quant Money Managers Limited
1.76%
Vanguard Group Inc
1.58%
Nippon Life India Asset Management Ltd
1.07%
Canara Robeco Asset Management Co. Ltd.
0.80%
BlackRock Fund Advisors
0.69%
Top mutual fund holders
Vanguard Total Intl Stock Idx Fund
0.68%
Vanguard Emerging Markets Stock Idx Fund
0.67%
HBM Healthcare Investments AG
0.52%
DSP Equity Opportunities
0.50%
iShares Core MSCI Emerging Markets ETF
0.46%
About Jubilant Pharmova
Jubilant Pharmova Ltd is an integrated global pharmaceutical company. The company's segment includes Radiopharma; Allergy Immunotherapy; Contract Development and Manufacturing Organisation - Sterile Injectables; Generics; Contract Research, Development and Manufacturing Organisation and Proprietary Novel Drugs. It generates maximum revenue from the Radiopharma segment. Geographically, it derives a majority of its revenue from Americas and Europe.
Company address
1A, Sector 16A, Noida, UP, 201
Key executives
Name
Title
Age
Mr. Arvind Chokhany
CFO/Director
49 yrs
Mr. Hari Shanker Bhartia
Co-Chairman/Director/Managing Director
64 yrs
Mr. Arjun Shanker Bhartia
Director/Managing Director
34 yrs
Mr. Priyavrat Bhartia
Director/Managing Director
NA

FAQs

How to Buy Jubilant Life Sciences Ltd Stock?
What is the Share Price of Jubilant Life Sciences Ltd?
What is the Market Cap of Jubilant Life Sciences Ltd?
In which sector / industry does Jubilant Life Sciences Ltd operate?
What was the revenue of Jubilant Life Sciences Ltd?
What is the PE ratio of Jubilant Life Sciences Ltd?
What is the 52 week high price of Jubilant Life Sciences Ltd?
What is the 52 week low price of Jubilant Life Sciences Ltd?
Can fractional shares of Jubilant Life Sciences Ltd be purchased?